CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-20 | Watts Ryan J. President and CEO | Sale | −200 | $25.00 | $5K | 2,239,913 |
| 2023-04-20 | Watts Ryan J. President and CEO | Option exercise · Stock Option (right to buy) | −200 | 1,195,417 | ||
| 2023-04-13 | Schuth Alexander O. COFO and Secretary | Option exercise | +4,898 | $5.28 | $26K | 533,589 |
| 2023-04-13 | Schuth Alexander O. COFO and Secretary | Sale | −4,898 | $25.04 | $123K | 528,691 |
| 2023-04-13 | Schuth Alexander O. COFO and Secretary | Option exercise · Stock Option (right to buy) | −4,898 | 88,937 | ||
| 2023-04-12 | Schuth Alexander O. COFO and Secretary | Option exercise | +5,102 | $5.28 | $27K | 533,793 |
| 2023-04-12 | Schuth Alexander O. COFO and Secretary | Sale | −5,102 | $25.04 | $128K | 528,691 |
| 2023-04-12 | Schuth Alexander O. COFO and Secretary | Option exercise · Stock Option (right to buy) | −5,102 | 93,835 | ||
| 2023-02-15 | Ho Carole Chief Medical Officer | Sale | −1,476 | $29.40 | $43K | 182,809 |
| 2023-02-13 | Krognes Steve E. Director | Sale | −2,119 | $30.10 | $64K | 143,002 |
| 2023-02-13 | Schuth Alexander O. COFO and Secretary | Option exercise | +25,000 | $0.68 | $17K | 524,902 |
| 2023-02-13 | Schuth Alexander O. COFO and Secretary | Sale | −3,497 | $30.09 | $105K | 528,691 |
| 2023-02-13 | Schuth Alexander O. COFO and Secretary | Option exercise · Stock Option (right to buy) | −25,000 | 195,078 | ||
| 2023-02-13 | Watts Ryan J. President and CEO | Sale | −8,815 | $30.09 | $265K | 2,239,913 |
| 2023-02-13 | Watts Ryan J. President and CEO | Option exercise | +25,000 | $0.68 | $17K | 2,264,913 |
| 2023-02-13 | Watts Ryan J. President and CEO | Sale | −25,000 | $30.08 | $752K | 2,239,913 |
| 2023-02-13 | Watts Ryan J. President and CEO | Option exercise · Stock Option (right to buy) | −25,000 | 1,195,617 | ||
| 2023-02-13 | Ho Carole Chief Medical Officer | Sale | −2,548 | $30.10 | $77K | 184,285 |
| 2023-02-10 | Ho Carole Chief Medical Officer | Sale | −818 | $29.80 | $24K | 179,365 |
| 2023-02-10 | Watts Ryan J. President and CEO | Option exercise | +25,000 | $0.68 | $17K | 2,254,031 |
Page 12 of 53 · 1,043 trades